But it wasn't designed to keep people in .
If the clinical trajectory follows the pre‑clinical promise, KBI‑110 could become , opening a new therapeutic class. KBI-110
Research on KBI-110 has revealed a range of potential benefits, including: But it wasn't designed to keep people in